Impact of Linagliptin vs Glimepiride on Glycemic Variability in Subjects with Type 2 Diabetes Mellitus at High Cardiovascular Risk: a substudy of the CAROLINA trial [SUBSTUDY OF 700191596]
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Linagliptin (Primary) ; Glimepiride
- Indications Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms CAROLINA CGM; Carolina Sub-study 1
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 09 Jun 2015 Results for baseline characteristics presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 31 Jan 2013 New trial record